We've established the Evan T. Mandeville DIPG Research Fund at Dana-Farber Cancer Institute in memory of our son Evan who, on November 13, 2012, lost his battle to Diffuse Intrinsic Pontine Glioma (DIPG).  He was just 11 years old.

Evan participated in two clinical trials during his exactly one year battle.  Clinical trials are the ONLY hope for this devastating diagnosis.  We are doing what we can to support efforts to find a cure for DIPG; this rare, always fatal and under-funded pediatric brain tumor. 

 ​100% of all donations made through the Pan-Mass Challenge go directly to Evan's research fund.

Dr. Mark Kiernan, MD, Ph.D
Pediatric Neuro-Oncologist speaking to the importance of funding.​

We are helping

Evan T. Mandeville Research Fund: DIPG Report

Reprinted with permission from Dana-Farber Cancer Institute.  To learn more, visit www.dana-farber.org."​​


Copyright 2023: Evan's Crew - Towards a cure. 

Research Fund

Evan's Crew: Towards a cure for DIPG

Raised to date:  $1.4 Million

2022: $231,092

2021: $156,104

2020: $134,512

2019: $196,428

2018: $171,533

2017: $140,921

2016: $154,454
2014: $104,289 
2013: $80,206